Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for BioCryst Pharmaceuticals, Inc. (BCRX)

« Back to company index

BCRX Chatter Timeline

Stock Ticker for BCRX

Most Active Tweeters for BCRX

UserTweets
@1MinuteStock 7
@dispatchtribune 3
@Allstocknews 3
@mmahotstuff1 3
@ledgerzette 3

Recent Tweets for BCRX

OlympiaReport @OlympiaReport
BioCryst Pharmaceuticals $BCRX Upgraded at Zacks Investment Research https://t.co/m7TLdItCg1
July 15th 2018, 4:07am
WeekHerald @WeekHerald
BioCryst Pharmaceuticals $BCRX Upgraded at Zacks Investment Research https://t.co/y0u9Lky70G
July 15th 2018, 4:07am
1MinuteStock @1MinuteStock
Wondering about risks of $BCRX? The 21-day volatility is 9.17% https://t.co/PJkDMq8jaV
July 15th 2018, 2:07am
ZolmaxNews @ZolmaxNews
BioCryst Pharmaceuticals $BCRX Raised to Hold at Zacks Investment Research https://t.co/xceyNZgyHB
July 15th 2018, 1:07am
1MinuteStock @1MinuteStock
We calculated 63-day Expected Return of $BCRX for you: 27.32% https://t.co/4OrKLaoWZt
July 15th 2018, 12:07am
1MinuteStock @1MinuteStock
Recommendation #HOLD for $BCRX with UB rating - 2.71 out of 5. https://t.co/w28BWt2PIs
July 15th 2018, 12:07am
sttocks @sttocks
Sold at $6.10 for 7% of profit. $bcrx. It was only swing play.
July 13th 2018, 12:07am
mmahotstuff1 @mmahotstuff1
BioCryst Pharmaceuticals, Inc. $BCRX EPS Estimated At $-0.22 - https://t.co/E4pUZNZDBo
July 12th 2018, 1:07pm
dakotafinancial @dakotafinancial
Zacks Investment Research Upgrades BioCryst Pharmaceuticals $BCRX to Hold https://t.co/Rtpu7KXyLj
July 12th 2018, 5:07am
ledgerzette @ledgerzette
BioCryst Pharmaceuticals $BCRX Upgraded to Hold at Zacks Investment Research https://t.co/BCyBJO6Fuk
July 12th 2018, 5:07am
ConsumerFeed @ConsumerFeed
BioCryst Pharmaceuticals $BCRX Sets New 1-Year High at $6.69 https://t.co/R9HBCjLzP0
July 12th 2018, 4:07am
reurope_stock @reurope_stock
Here's how analysts see BioCryst Pharmaceuticals, Inc. $BCRX after this past week. https://t.co/WNtcCYfLTQ
July 11th 2018, 2:07pm
mmahotstuff1 @mmahotstuff1
Are Analysts Bullish about BioCryst Pharmaceuticals, Inc. $BCRX after last week? - https://t.co/p7KIR9sgSt
July 11th 2018, 2:07pm
whatsonthorold2 @whatsonthorold2
This is what analysts have to say about BioCryst Pharmaceuticals, Inc. $BCRX after last week. - https://t.co/tXbkXudE37
July 11th 2018, 2:07pm
The_CasualSmart @The_CasualSmart
How Many BioCryst Pharmaceuticals, Inc. $BCRX's Analysts Are Bullish? https://t.co/Ky9Ohfh8tv
July 11th 2018, 2:07pm
1MinuteStock @1MinuteStock
Unicorn Bay rating for $BCRX is 2.71 out of 5. https://t.co/N5TSgwGdLT
July 11th 2018, 12:07pm
bibeypost_stock @bibeypost_stock
What Next for BioCryst Pharmaceuticals, Inc. $BCRX Stock After Reaching 52-Week High? - https://t.co/RRgUIPjBgN
July 11th 2018, 10:07am
mmahotstuff1 @mmahotstuff1
How Analysts Feel About BioCryst Pharmaceuticals, Inc. $BCRX After Touching 52-Week High? - https://t.co/YMPhIpysOC
July 11th 2018, 10:07am
ThisLincolnian @ThisLincolnian
BioCryst Pharmaceuticals $BCRX Upgraded to Hold at Zacks Investment Research https://t.co/sgsHaRvTHH
July 11th 2018, 10:07am
Briefingcom @Briefingcom
$BCRX: BioCryst Pharma updates on strategic and financial outlook following termination of merger agreement with... https://t.co/wBLun0OrAY
July 11th 2018, 10:07am
jfais20 @jfais20
$BCRX JMP Securities Outperform rating with $12 price target, not overly surprised that majority of shareholders vo… https://t.co/gNqGjEGBga
July 11th 2018, 9:07am
happyycamperr @happyycamperr
Was reading latest PR from $BCRX and decided to do a little DD...first thing was to read @JacobPlieth.....no need t… https://t.co/shF5nPkD17
July 11th 2018, 9:07am
SwingTradeBot @SwingTradeBot
Recent $BCRX technical alerts: Bollinger Band Squeeze plus 7 more alerts... https://t.co/H1RerNBTXd
July 11th 2018, 9:07am
StockTexts @StockTexts
$BCRX BioCryst Pharmaceuticals, Inc. SEC Filing: Form 8-K https://t.co/DV5ponedgw
July 11th 2018, 8:07am
JacobPlieth @JacobPlieth
That all new $BCRX strategy we've all been waiting for https://t.co/DMJg7rngqs
July 11th 2018, 8:07am
portefeuillefun @portefeuillefun
RT @odibro: $BCRX Provides Update on Strategy, Pipeline and Outlook https://t.co/sibyl8mdzC
July 11th 2018, 8:07am
Allstocknews @Allstocknews
$BCRX BioCryst Provides Update on Strategy, Pipeline and Outlook From our Stock News Alerts App
July 11th 2018, 8:07am
odibro @odibro
$BCRX Provides Update on Strategy, Pipeline and Outlook https://t.co/sibyl8mdzC
July 11th 2018, 8:07am
VisualStockRSRC @VisualStockRSRC
$BCRX - BioCryst Provides Update on Strategy, Pipeline and Outlook https://t.co/K6WtvBlxaK
July 11th 2018, 8:07am
greenpenny2016 @greenpenny2016
$BCRX - BioCryst Provides Update on Strategy, Pipeline and Outlook https://t.co/Y2JKyhZjDk
July 11th 2018, 8:07am
BehaviorFin @BehaviorFin
RT @tgtxdough: JMP $BCRX continue to recommend BCRX shares as we believe there is a disconnect between investor and physician perceptions o…
July 11th 2018, 8:07am
1MinuteStock @1MinuteStock
Explore #fundamental numbers and pros and cons for $BCRX https://t.co/FmL0JRPwI2
July 11th 2018, 6:07am
tgtxdough @tgtxdough
JMP $BCRX continue to recommend BCRX shares as we believe there is a disconnect between investor and physician perc… https://t.co/uPTrB9L5UP
July 11th 2018, 6:07am
1MinuteStock @1MinuteStock
Wondering about #sentiment indicator for $BCRX? The Short Ratio is 11.8% https://t.co/7C2cyLUJCz
July 10th 2018, 8:07pm
1MinuteStock @1MinuteStock
Wondering about risks of $BCRX? The 63-day volatility is 25.4% https://t.co/PJkDMq8jaV
July 10th 2018, 8:07pm
EnterpriseLeade @EnterpriseLeade
Zacks Investment Research Upgrades BioCryst Pharmaceuticals $BCRX to Hold https://t.co/6N2e5J3SeI
July 10th 2018, 8:07pm
dispatchtribune @dispatchtribune
Zacks Investment Research Upgrades BioCryst Pharmaceuticals $BCRX to Hold https://t.co/Jw8G2tCV1W
July 10th 2018, 7:07pm
Briefingcom @Briefingcom
$BCRX: BioCryst Pharma terminates merger agreement with Idera Pharma https://t.co/kfgynNyrm0
July 10th 2018, 6:07pm
portefeuillefun @portefeuillefun
@zzlangerhans Bought 1000 $BCRX at $6.32, now 1000 #vssporte shares.
July 10th 2018, 5:07pm
MarketChmln @MarketChmln
$BCRX gains in after hours trading. See the latest news. https://t.co/IpzOIjzK9p https://t.co/DtP6P3uFCy
July 10th 2018, 5:07pm
Allstocknews @Allstocknews
$BCRX New Form SC 13G/A for BioCryst Pharmaceutical, Inc. From our Stock News Alerts App
July 10th 2018, 4:07pm
DewDiligence @DewDiligence
@JacobPlieth The $BCRX program in HCV was never a serious one, IMO: https://t.co/CVmNpebKaS
July 10th 2018, 4:07pm
ByJonGardner @ByJonGardner
RT @JacobPlieth: $BCRX history under J Stonehouse: peramivir (fail), hep C (discontinued), gout (fail), HAE (fail), failure to buy Presidio…
July 10th 2018, 4:07pm
ByJonGardner @ByJonGardner
$BCRX left at the altar again?
July 10th 2018, 4:07pm
JacobPlieth @JacobPlieth
$BCRX history under J Stonehouse: peramivir (fail), hep C (discontinued), gout (fail), HAE (fail), failure to buy P… https://t.co/pc8NEAZkXu
July 10th 2018, 4:07pm
fascination_bio @fascination_bio
$bcrx turns down a merger with a company that has a proven hae ceo in order to remain with the old ceo that wanted… https://t.co/Fj4Une81Fd
July 10th 2018, 4:07pm
Stock_News_Now @Stock_News_Now
$BCRX: New SEC Filing for BCRX: Form SC 13G/A (No. 0001274173-18-000092): https://t.co/RUleXoh8Ys
July 10th 2018, 4:07pm
MareaInformativ @MareaInformativ
BioCryst Pharmaceuticals $BCRX Reaches New 52-Week High at $6.69 https://t.co/Fo1kvTNYBz
July 10th 2018, 4:07pm
dispatchtribune @dispatchtribune
BioCryst Pharmaceuticals $BCRX Reaches New 1-Year High at $6.69 https://t.co/mOYSUNxJl3
July 10th 2018, 4:07pm
EnterpriseLeade @EnterpriseLeade
BioCryst Pharmaceuticals $BCRX Reaches New 52-Week High at $6.69 https://t.co/BUf5LhpEP1
July 10th 2018, 4:07pm

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.